Clinical Trial Detail

NCT ID NCT02234921
Title Pilot Study of DRibble Vaccine for Prostate Cancer Patients
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors UbiVac
Indications

prostate cancer

Therapies

Cyclophosphamide

Age Groups: adult

No variant requirements are available.